SANTA CLARA, Calif., June 23, 2025--Ancora Heart has reached the first enrollment milestone in the CORCINCH-HF pivotal trial of the AccuCinch® System in patients with heart failure.

Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company’s lead product is the AccuCinch ® Transcatheter Left Ventricular ...

Doctors at the Abrazo West Campus in Goodyear used the world's smallest heart pump to save a Buckeye woman's life earlier ...

Kolkata: Eastern India's first-ever case of Bachmann's Bundle (BB) Pacing and Left Bundle Branch Area Pacing (LBBAP), a dual strategy that mimics the .

InterShunt Technologies has initiated the EASE HF2 early feasibility study to assess the InterShunt percutaneous atrial shunt ...

A new discovery could change the outlook for heart failure patients by identifying ways to lower stroke risk after LVAD implantation.

Crash prediction models may have limited ability to predict motor vehicle crashes after the implantation of a cardioverter-defibrillator.

Red-light devices are all over social feeds and make enormous promises. From the many, we find the few that are actually worth your commitment, time, and money.

Intuitive Surgical announced today that the FDA cleared the latest advanced energy instrumentation for its da Vinci systems.

The NHS has begun giving patients a new DIY heart monitor which looks for heart rhythm problems. Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent ...